Lutonix enrolls first patient in LEVANT 2 trial

Friday, July 29, 2011

Lutonix has enrolled its first patient in the LEVANT 2 clinical trial, a global, multi-center, randomized trial evaluating the safety and efficacy of the Moxy(TM) Drug Coated Balloon compared to a standard angioplasty balloon for the treatment of peripheral arterial disease (PAD).  The first case was performed at St. John’s Hospital in Springfield, Ill., by Dr. Jeff Goldstein.

[Read More]